Background: Echovirus 6 (E6), is one of the main enteroviral serotypes, was initially isolated from patients with aseptic meningitis (AM) and is a major cause of hospitalization among children and adults worldwide. Methods: A cerebrospinal fluid (CSF) sample was collected from patient with clinically suspected aseptic meningitis (AM) in August 2011. Following detection of a virus and subsequent virus serotyping, the whole genome sequence was determined. The sequence of the VP1 region of the isolated strain E6 RA/E6/Ahvaz/Iran/2011 showed 79% (>75%) nucleotide and 94% (>85%) amino acid homology with prototype strain D'Amori. The isolated strain was identified as an E6 serotype. A specimen was cultured in a human rhabdomyosarcoma (RD) cell line. Following propagation, the virus was further analyzed using the plaque assay technique, reverse transcription PCR (RT-PCR), rapid amplification of CDNA ends (RACE), TA cloning, sequencing, phylogenetic analysis, Simplot and boot scanning analyses (ver. 3.5) were applied to find evidence of recombination in the isolated strain. Results: The isolated Echo6 strain RA/E6/Ahvaz/Iran/2011 has been recorded in GenBank with a partial and complete genome accession numbers (KX619440) (KX198605), respectively. The complete genomic sequence was 7435 nt, with a 742 bp 5 0 UTR, 117 bp 3 0 UTR, and an open reading frame (ORF) encoding a polypeptide of 2191 amino acids. The nucleotide analysis of the VP1 and structural genomic regions of the isolated strain showed high similarity with strain E6-10887-99 isolated from patient with facial nerve paresis in Russia in 1999. The recombinations evidence were observed in the isolated strain E6 RA/E6/Ahvaz/Iran/2011 and found to have a high levels of inter-serotypic exchanges in 2C and 3A-3C genomic regions with Echovirus13 and Echovirus14, respectively. Conclusion: Full genome sequence analysis of enteroviral is required to understand the epidemiological pattern and to evaluate the new enterovirus circulating in community.
Introduction
The new order Picornavirales includes the Picornaviridae family, and the Enterovirus (EV) genus is one of the best characterized genera in this family. 1, 2 Human enteroviruses (HEVs) are divided into four species, HEVs A to D, and consist of more than 110 serotypes. 1, 3 They are nonenveloped, small icosahedral and single-stranded (þ) sense RNA viruses with a genome about 7.5 kilobases (kb) in length, containing a single open reading frame (ORF) encoding a polyprotein. The coding region is divided into three subregions: P1 encodes the structural proteins (VP4, VP2, VP3, and VP1) and the P2 and P3 regions encode non-structural proteins. In the P2 region, 2A encodes a protease and Conflicts of interest: The authors declare that they have no conflicts of interest related to the subject matter or materials discussed in this article.2Be2C encodes two proteins involved in replication of RNA and inhibition of host cell gene expression. Region P3 contains 3A (encodes membrane-anchored factors and an RNA-binding protein), 3B (encodes a genome-linked protein called VPg), 3C (encodes a viral protease), and 3D (encodes an RNAdependent RNA polymerase). 3, 4 Human enteroviruses are very contagious; they are typically spread by the fecal-oral route and can also be spread by respiratory routes and from mother to infant in the peripartum period. 5 Human enteroviruses infect an estimated billion or more persons each year worldwide. 3, 6 More than ninety percent of enterovirus infections are benign, self-limiting, and asymptomatic; but a fraction of enteroviruses cause severe and life-threatening illnesses, such as aseptic encephalitis, aseptic meningitis (AM), summer colds, epidemic myalgia, acute myocarditis, acute flaccid paralysis (AFP), acute hemorrhagic conjunctivitis (AHC), acute childhood viral exanthema, and hand, foot, and mouth disease (HFMD), which are public health problems worldwide. 5, 7, 8 Enteroviruses were traditionally typed by neutralization reaction tests, but the results were often ambiguous. Today, typing is based on the sequence of the VP1 capsid protein and the typing protocol has been replaced by molecular methods that provide a comprehensive genetic characterization of each enterovirus serotype. 8, 9 The definitions of enterovirus serotypes are based on nucleotide and amino acid similarities; thus, the same serotype is defined as having >75% nucleotide similarity or >85% amino acid sequence similarity in the VP1 coding sequence. 9 High rates of mutations and recombinations have been reported among the different enteroviruses serotypes, providing mechanisms for frequent enterovirus evolution. 8 The rate of genetic recombination is correlated with the endemicity of virus populations and the repeated or timecorrelated cycles of emergence of HEVs. 7, 10 Currently, no effective medicines, antiviral treatments, or vaccines are available for many of the enteroviral infections in the Picornaviridae family. 11 In the present study, a cerebrospinal fluid (CSF) sample was collected from a patient with aseptic meningitis. The aim was to detect the virus, to perform serotyping, and to determine the whole genome sequence. Full genome analysis is necessary for a more comprehensive understanding of epidemiological events involving enteroviruses serotypes. 7 This is the first description of the complete genome sequence of the E6 strain causing AM in Iran.
Methods

Patient and clinical sample
A CSF sample was obtained from a female infant with clinical signs and symptom of AM who was hospitalized at the Razi University Hospital (Ahvaz, Iran) in August 2011. The sample was delivered to the virology laboratory and stored at À70 C. First diagnosis showed positive for enterovirus by amplification of the 5 0 untranslated region (UTR) by Reverse transcription polymerase chain reaction (RT-PCR). 12 Subsequently, the VP1 RT-PCR amplification assay was used to identify molecular typing of the isolated strain. 
. Preparation of virus stocks
The CSF sample was inoculated and grown on a human rhabdomyosarcoma (RD) cell line at 37 C in a 5% CO 2 atmosphere for 5e6 days. The cells were observed for signs of cytopathic effects (CPEs) for 24 h. The medium in each well was then decanted, the wells were washed twice with phosphate-buffered saline (PBS, Bio-Idea, Iran), and then the medium was replaced with fresh 1x Dulbecco's Modified Eagle Medium (DMEM; Bio-Idea, Iran) supplemented with 10% heat inactivated fetal bovine serum (FBS; Bio-Idea, Iran) and 1% penicillin (100 U/mL)/streptomycin (100 mg/ml) (Pen/strep, Bio-Idea, Iran). Subsequently, when the CPEs were observed, suspensions of pure-culture virus were prepared by multiple freezing (À20 C) and thawing (37 C) cycles and a final vortexing.
Double layer agar plaque assay
Pure virus was isolated using a plaque assay on double layer agar (DLA). A 150 ml volume of tenfold serially diluted virus particles (10 À4 to 10 À8 dilutions) was seeded, along with a negative control, into 6-well plates (SigmaeAldrich) containing confluent monolayers of RD cells (1 Â 10 5 cells/cm 2 ). After absorption of the viruses at 37
C for 1 h, 3 ml of 2x DMEM (Bio-Idea, Iran) was mixed with an equal volume of 1.5% purified cell culture grade agar (SigmaeAldrich, cat NO 1296) supplemented with 1% heat inactivated fetal bovine serum (FBS, Bio-Idea, Iran), overlaid as a monolayer in the 6-well plates (SigmaeAldrich), and incubated overnight at 37 C in 5% CO 2 . Another 3 ml of 2x DMEM containing 1.5% agar was overlaid onto the 6-well plate and stained with 0.01% neutral red (SigmaeAldrich, cat. NO. 4638). The plate was sealed with aluminum foil to protect it from light and incubated overnight at 37 C in 5% CO 2 . Three plaques were picked up and passaged three times in a 25 cm 2 flask containing confluent RD cells. Incubation was continued until CPEs were observed, and the culture was then stored at À70 C for further study. 13 
RNA extraction, RT-PCR, and rapid amplification of cDNA ends (RACE)
Viral RNA was extracted from cell culture supernatant using a QIAamp viral RNA minikit (Qiagen, Westburg, The Netherlands) according to the manufacturer's instructions. In this study, whole genome sequences were obtained by designing some primers according to 16 conserved regions of several complete genome strains of E6 retrieved from GenBank (Table 1 ). All primers were synthesized by Metabion (Martinsried, Germany). First, the cDNA was prepared using a RevertAid First Strand cDNA Synthesis Thermo Kit (cat. NO. K1622) according to the manufacturer's instructions. The RT-PCR was then carried out for conserved regions of the sample. Rapid amplification of CDNA ends (RACE) was carried out for both the 5 0 and 3 0 ends of the isolated RA/E6/Ahvaz/Iran/2011. The 5 0 ends were sequenced using a 5 0 RACE kit (5 0 Core Set, Takara, Japan, cat. NO. 6122) with primers 405AHCDNAR, 293AH5S1, 239AH5A1, 317AH5S2, and 211AH5A2, according to the manufacturer's instructions. The entire 3 0 ends were sequenced using a 3 0 Full RACE Core Set kit (Takara, Japan, cat. NO 6121) with an oligo dT-3'site adaptor, a 3'site adaptor, and 6522AH6F primers, according to the manufacturer's instructions.
TA cloning
All the PCR products were extracted from the agarose gel and cleaned up before ligation using a purification kit (High Pure PCR Product Purification Kit, Roche Life Sciences). Subsequently, all the PCR products were cloned into a plasmid (pTZ57R/T) using a TA cloning kit (InsTAclone PCR Cloning Kit, Thermo Fisher Scientific). The cloned plasmids were transformed into E. coli DH5a and then amplified in LB media. The plasmids carrying PCR products were then purified using a plasmid DNA extraction kit (Yekta Tajhiz Azma (YTA), Iran).
Sequencing
The purified plasmids carrying the PCR products were analyzed by agarose gel electrophoresis (CinnaGen, Iran). The PCR products of different regions of strain RA/E6/Ahvaz/Iran/ 2011 were sequenced in both directions. Potentially ambiguous nucleotides were avoided by using the analyzer (Macrogen Europe, Inc.) followed by Sanger sequencing. The sequence assembly was performed manually.
Typing with VP1
The VP1 sequence was compared with sequences retrieved from GenBank using the online nucleotide BLAST [National Center for Biotechnology Information (NCBI)] (http://www. ncbi.nlm.nih.gov/BLAST/). The sequence of VP1 was identified as Echovirus 6 (E6) with 79% nucleotide similarity to the prototype strain D'Amori. 
Nucleotide sequence accession numbers
The partial and complete nucleotide sequences of the RA/ E6/Ahvaz/Iran/2011 strain were recorded in GenBank with accession numbers KX198605 and KX619440, respectively. 
Multiple sequence alignment and phylogenetic analysis
Multiple sequence alignment (MSA) was carried out using online Clustal Omega software from the EMBL-EBI website (European Molecular Biology Laboratory-European Bioinformatics Institute) (http://www.ebi.ac.uk/Tools/msa/clustalo/). Phylogenetic trees were constructed by the neighbor-joining (NJ) method with maximum composite likelihood (MCL) distances method and 1000-replication bootstrap test, using the MEGA software (version 6). In addition to the transitions/ transversions, bootscanning and Simplot (version 3.5.1) were used to analyze and find evidence for recombinant regions in this isolated strain.
Results
RA/E6/Ahvaz/Iran/2011 strain was isolated from CSF sample of a patient with clinically suspected AM in Ahvaz city, Iran in August 2011. Sequencing of the VP1 genomic region revealed that the isolated strain belongs to the E6 serotype with 79% (>75%) nucleotide identity and 94% (>85%) amino acid identity with the E6 prototype strain D 0 Amori. 9 The new isolated strain was 7435 nt in length, with a 742 bp 5 0 UTR, 117 bp 3 0 UTR, and an open reading frame (ORF) encoding a polypeptide of 2191 amino acids. The phylogenetic trees of VP1-VP4 and P1 regions of the isolated strain with other prototype strains of HEV-B showed the isolated strain was clustered with its prototype strain D 0 Amori (data for VP4-VP2-VP3 not shown) (Fig. 1A and B) . The VP1 and complete genome sequences of the isolated strain, showed 89% and 86% nucleotide similarity with the isolated strain E6-10887-99 (AY896760) from a patient with facial nerve paresis in Russia in 1999, respectively. 16 In this study, the nucleotide and amino acid sequences of the different genomic regions of the isolated strain were compared with the prototype strain D 0 Amori and strain E6-10887-99 ( Table 2 ). The nucleotide sequence of 5 0 UTR region showed highest nucleotide similarity with D 0 Amori and E6-10887-99 strains (89%). The nucleotide sequence of P1 region displayed higher sequence identity to strain E6-10887-99 (87%) than to strain D 0 Amori (79%). In the P2 and P3 genomic regions, the nucleotide sequence identity to D 0 Amori and E6-10887-99 strains, were ranged from 77% to 88%. The highest level of nucleotide divergence was observed between the isolated strain and those of D'Amori, E6-10887-99 strains in 3B (77%) and 3A (80%) regions, respectively. The amino acid sequences of the isolated strain were highly conserved with homology identity of 94%e99% in structural and 91%e 98% in non-structural regions with D 0 Amori and E6-10887-99 strains.
In order to investigate recombination phenomenon, the analysis of phylogenetic trees of the different genomic regions of the isolated strain (data not shown), bootscaning and similarity plot were carried out with other strains of HEV-B.
Regarding 5
0 UTR region, phylogenetic tree showed the isolated strain clustered with other strains of HEV-B specious (cluster II) 5 with very low bootstrap support. The P1 genomic region, was found very closed to strain E6-10887-99 with 87% similarity. The analysis of 2A region showed robust bootstrap support, and clustered with strain E6-10887-99. The 2C coding region was clearly related with several Echovirus 13 (E13) strains isolated in japan in 2002. The P3 coding region with strong bootstrap values was clustered with Echovirus 14 (E14) strain P968/2013 (KP289441), Coxsackievirus B3 (CBV3) strain 18219-02 (AY896763), Enterovirus 85 (EV85) strain HTPS-MKLH04F/XJ/CHN/2011 (JX898907) and E6-10887-99. Simplot analysis of the complete genome of E6 strain RA/E6/Ahvaz/Iran/2011 was carried out. The structural coding region of the isolated strain, displayed highest degree of identity with strain E6-10887-99. The sequence similarity in VP1-2A junction region was dropped. It is obvious that recombination event with E13 strain 2002-240-SF has been occurred in the 2C genomic region which was isolated from AM patient in Japan. 17 In addition, the other recombination phenomenon have been taken place in the 3A to 3C genomic regions of isolated strain with E14 strain P968/2013 obtained from HFMD patient in China. 18 ( Fig. 2A) The analysis of bootscaning graph in 3 0 half of 2C and 3A-3C genomic regions of the isolated strain exhibited more than 95% similarity with E13 and E14 strains, respectively (Fig. 2B ).
Discussion
In this study, the full genome sequence of a novel recombinant Echovirus 6 (strain E6 RA/E6/Ahvaz/Iran/2011) was analyzed which isolated from CSF sample of a patient with clinically suspected AM (headache, fever, vomiting, nausea, neck stiffness) in 2011. This is a first report in complete genome sequence of the isolated E6 strain in Iran. These Table 2 Nucleotide and amino acid sequence identities between the E6 RA/E6/Ahvaz/ Iran/2011 strain, strain prototype D'Amori and strain E6-10887-99.
Genomic region
Nucleotide sequence identity (%) finding might provide a clue for further comprehensive understanding of other E6 strains. An outbreak of E6 in pediatric with AM have been reported in many regions of the world. 15 The constructed phylogenetic trees for VP1 and P1 regions of isolated strain and prototype strains of other HEV-B serotypes showed the isolated strain clustered with prototype strain D 0 Amori. The sequence of the different regions of the isolated strain showed significant difference with prototype strain D 0 Amori, isolated in the United States in 1995, 19 and lower difference with the E6-10887-99 strain.These findings indicate that the newly E6 strains isolated from different regions were closed to each other than to the corresponding prototype strain. 16 The nucleotide identity score for VP1 region (89%) with complete genome (86%) of the isolated strain in compare with strain E6-10887-99, indicating a simultaneous co-infection of the E6 strain with other enterovirus serotypes, which may result in entero-serotypic recombination. The genetic recombinations among polioviruses and in other enteroviruses are well-documented. 5, 14, 20 A lack of proofreading in the RNA-dependent RNA polymerase (RdRp) gene of the HEVs may lead to occurrence of mutations during RNA synthesis. 21, 22 The rate of nucleotide substitutions among the enteroviruses vary from 1 to 2% per year. 23 The constructed phylogenetic trees in non-structural regions of the isolated strain showed the significant difference as compare with structural region, indicating the evidence of recombinations in this regions (data not shown). The results of Simplot analysis have been observed drop abruptly in similarities of non-structural regions (P2 and P3) compare with structural region strain E6 RA/E6/Ahvaz/Iran/2011 and other serotype of HEV-B (Fig. 2A) . These findings strongly support the occurrence of inter-typic recombination events. High levels of inter-serotypic were determined by bootscaning analysis and the role of 2C and 3A-3C genomic regions as the hot spots in recombination events have been observed with E13 and E14 strains respectively.
The identification of enteroviruses serotypes are based on structural sequences region, 16 whereas the virulence of the enteroviruses rely on non-structural sequences. 24 Thus diagnosis of the enteroviruses based only on the structural region may not be sufficient to understand the pathogenicity of enteroviruses. 7 Finally, viral recombination, following genetic exchanges can give rise to new recombinant viruses with increased virulence which may result in devastating outbreaks with burden diseases in community. 25, 26 Full genome sequence analysis of enteroviral strains is therefore required to understand the epidemiological patterns and also to evaluate the evidence of new circulating recombinant strains enteroviruses.
